NASDAQ: SRPT Long Term Investor Notice: Investigation over Possible Wrongdoing at Sarepta Therapeutics, Inc.
An investigation on behalf of current long term investors in Sarepta Therapeutics, Inc. (NASDAQ: SRPT) shares over possible breaches of fiduciary duty by certain officers and directors was announced.
View full press release